NCT06454461View on ClinicalTrials.gov

Efficacy of Upadacitinib After NECS in Vitiligo

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 4, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2029

Conditions
Vitiligo
Interventions
DRUG

Upadacitinib 15 MG

Upadacinib 15mg once daily for the 8 weeks after NECS

Trial Locations (1)

130021

RECRUITING

Department of Dermatology and Venerology, The First Hospital of Jilin University, No. 1 Xinmin Street, Changchun

All Listed Sponsors
lead

Jilin University

OTHER